Latest Chronic kidney disease Stories
If Implemented, Program Risks Confusing, Misleading Patients and Public WASHINGTON, Aug.
NEW YORK, July 17, 2014 /PRNewswire/ -- La Jolla Pharmaceutical Company (NASDAQ: LJPC) is a biopharmaceutical company focused on the development of therapeutic agents that inhibit the activity
NxStage Patient Advocates to travel the East Coast to share the benefits of home hemodialysis LAWRENCE, Mass., July 16, 2014 /PRNewswire/ -- NxStage® Medical, Inc.
BUFFALO, N.Y., July 11, 2014 /PRNewswire/ -- CTG (NASDAQ:CTG) today announced that Laura Argauer, software engineer at CTG and John Gillespie M.D., M.B.A., Chief Medical Officer at Palladian
Interest in GCS-100, Velcalcetide, ST-10, GSK-1278863A and Rayaldee Ranges from Moderate to High, According to Findings from Decision Resources Group BURLINGTON, Mass., July 10, 2014 /PRNewswire/
STOCKHOLM, July 10, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, has had core patents for its late-stage clinical
World-class Nephrologist to Lead Home Dialysis Program DENVER, July 9, 2014 /PRNewswire-USNewswire/ -- DaVita Kidney
NEW YORK, July 7, 2014 /PRNewswire/ -- Mariel Therapeutics, Inc.
NxStage Patients embrace the flexibility of home hemodialysis to reclaim their lifestyles and live freely LAWRENCE, Mass., July 3, 2014 /PRNewswire/ -- In honor of Independence Day,
Acute kidney injury (AKI) and chronic kidney disease (CKD) are closely intertwined, with each disease a risk factor for developing the other and sharing other risk factors in common, as well as sharing causes for the diseases to get worse, and outcomes.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.